FLR
52
4
EA
63
3
DE
46
4
PH
70
-4
CL
56
5
F
59
3
EQR
56
2
ALLE
30
-2
DAL
81
-3
TGT
50
5
SLG
59
2
NEM
40
4
EQIX
60
3
HPE
59
15
RSG
67
2
V
66
2
AA
43
-11
DIS
82
-3
BDX
52
-2
AEE
60
2
FLR
52
4
EA
63
3
DE
46
4
PH
70
-4
CL
56
5
F
59
3
EQR
56
2
ALLE
30
-2
DAL
81
-3
TGT
50
5
SLG
59
2
NEM
40
4
EQIX
60
3
HPE
59
15
RSG
67
2
V
66
2
AA
43
-11
DIS
82
-3
BDX
52
-2
AEE
60
2
Financhill
Back

Apellis Pharmaceuticals Vs. Avidity Biosciences Industry Stock Comparison

Sell
30

APLS
Apellis Pharmaceuticals

Last Price:
26.19
Seasonality Move:
20.78%
Sell
28

RNA
Avidity Biosciences

Last Price:
41.33
Seasonality Move:
39.98%
Sell
30
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.18. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $41.35. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $41.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 35.91 Sell
Chaikin Money Flow: -364136 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.93 - 28.79) Sell
Bollinger Bands (100): (28.92 - 38.96) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 40.82 Sell
Chaikin Money Flow: 357620 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.39 - 48.73) Sell
Bollinger Bands (100): (41.59 - 46.95) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.29 Sell
20-day SMA: 27.92 Sell
50-day SMA: 29.89 Sell
200-day SMA: 43.11 Sell
8-day EMA: 27.67 Sell
20-day EMA: 28.11 Sell
50-day EMA: 30.08 Sell
200-day EMA: 39.9 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.77 Sell
20-day SMA: 45.6 Sell
50-day SMA: 45.12 Sell
200-day SMA: 34.35 Buy
8-day EMA: 45.62 Sell
20-day EMA: 45.85 Sell
50-day EMA: 45.09 Sell
200-day EMA: 35.64 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.26 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):